Long-term prognosis of patients with pediatric pheochromocytoma

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 17-25

  Bausch, Birke ^a   Wellner, Ulrich ^b   Bausch, Dirk ^b   Schiavi, Francesca ^c   Barontini, Marta ^d   Sanso, Gabriela ^d   Walz, Martin K ^e   Peczkowska, Mariola ^f   Weryha, Georges ^g   Dall'Igna, Patrizia ^h   Cecchetto, Giovanni ^h   Bisogno, Gianni ^h   Moeller, Lars C ⁱ   Bockenhauer, Detlef ^j   Patocs, Attila ^k   Rácz, Karoly ^k   Zabolotnyi, Dmitry ^l   Yaremchuk, Svetlana ^l   Dzivite Krisane, Iveta ^m   Castinetti, Frederic ⁿ   Taieb, David ^o   Malinoc, Angelica ^a   Von Dobschuetz, Ernst ^a   Roessler, Jochen ^a   Schmid, Kurt W ⁱ   Opocher, Giuseppe ^c   Eng, Charis ^p   Neumann, Hartmut P H ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF PADOVA   (Italy)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^e KLINIKEN ESSEN MITTE   (Germany)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g UNIVERSITÉ DE LORRAINE   (France)

^h UNIVERSITY HOSPITAL OF PADOVA   (Italy)

ⁱ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^j Hospital Great Ormond Street ^*  (United Kingdom)

^k SEMMELWEIS UNIVERSITY   (Hungary)

^l NAMS of Ukraine   (Ukraine)

^m University of Riga   (Latvia)

ⁿ AIX MARSEILLE UNIVERSITY   (France)

^o TIMONE HOSPITAL   (France)

^p TAUSSIG CANCER INSTITUTE   (United States)

more..

Author keywords

Germline mutations; Long term follow up; Pheochromocytoma; Relapse

Indexed keywords

GENOMIC DNA; PARATHYROID HORMONE; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADRENAL TUMOR; AGE DISTRIBUTION; ARTICLE; CALCITONIN BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; HEMANGIOBLASTOMA; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NEUROFIBROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

GERMLINE MUTATIONS; LONG-TERM FOLLOW-UP; PHEOCHROMOCYTOMA; RELAPSE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SEQUENCE ANALYSIS, DNA;

EID: 84893617173     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0415     Document Type: Article

References (29)

1. Asari R, Scheuba C, Kaczirek K & Niederle B 2006 Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Archives of Surgery 141 1199-1205 (discussion 1205). (doi:10.1001/archsurg.141.12.1199)
2. Barontini M, Levin G & Sanso G 2006 Characteristics of pheochromocytoma in a 4- to 20-year-old population. Annals of the New York Academy of Sciences 1073 30-37. (doi:10.1196/annals.1353.003)
3. Bausch B, Borozdin W & Neumann HP 2006a Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. New England Journal of Medicine 354 2729-2731. (doi:10.1056/NEJMc066006)
4. Bausch B, Koschker AC, Fassnacht M, Stoevesandt J, Hoffmann MM, Eng C, Allolio B & Neumann HP 2006b Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 91 3478-3481. (doi:10.1210/jc.2006-0780)
5. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA et al. 2010 SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncology 11 366-372. (doi:10.1016/S1470-2045(10)70007-3)
6. Beltsevich DG, Kuznetsov NS, Kazaryan AM & Lysenko MA 2004 Pheochromocytoma surgery: epidemiologic peculiarities in children. World Journal of Surgery 28 592-596. (doi:10.1007/s00268-004-7134-9)
7. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, Jouanno E, Jeunemaitre X, Benit P, Tzagoloff A et al. 2010 SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics 19 3011-3020. (doi:10.1093/hmg/ddq206)
8. Cascon A, Inglada-Perez L, Comino-Mendez I, de Cubas AA, Leton R, Mora J, Marazuela M, Galofre JC, Quesada-Charneco M & Robledo M 2013 Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocrine-Related Cancer 20 L1-L6. (doi:10.1530/ERC-12-0339)
9. Ciftci AO, Tanyel FC, Senocak ME & Buyukpamukcu N 2001 Pheochromocytoma in children. Journal of Pediatric Surgery 36 447-452. (doi:10.1053/jpsu.2001.21612)
10. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro-Garcia LJ, Leton R, Honrado E, Ramos-Medina R, Caronia D, Pita G et al. 2011 Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature Genetics 43 663-667. (doi:10.1038/ng.861)
11. De Krijger RR, Petri BJ, Van Nederveen FH, Korpershoek E, De Herder WW, De Muinck Keizer-Schrama SM & Dinjens WN 2006 Frequent genetic changes in childhood pheochromocytomas. Annals of the New York Academy of Sciences 1073 166-176. (doi:10.1196/annals.1353.017)
12. Ein SH, Shandling B, Wesson D & Filler R 1990 Recurrent pheochromocytomas in children. Journal of Pediatric Surgery 25 1063-1065. (doi:10.1016/0022-3468(90)90219-Y)
13. Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE & Perrier ND 2013 Long-term outcomes of surgical treatment for hereditary pheochromocytoma. Journal of the American College of Surgeons 216 280-289. (doi:10.1016/j.jamcollsurg.2012.10.012)
14. Kaufman BH, Telander RL, van Heerden JA, Zimmerman D, Sheps SG & Dawson B 1983 Pheochromocytoma in the pediatric age group: current status. Journal of Pediatric Surgery 18 879-884. (doi:10.1016/S0022-3468(83)80040-2)
15. Khorram-Manesh A, Jansson S, Wangberg B, Nilsson O, Tisell LE & Ahlman H 2006 Mortality associated with pheochromocytoma: increased risk for additional tumors. Annals of the New York Academy of Sciences 1073 444-448. (doi:10.1196/annals.1353.048)
16. King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP et al. 2011 Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. Journal of Clinical Oncology 29 4137-4142. (doi:10.1200/JCO.2011.34.6353)
17. Mannelli M, Ercolino T, Giache V, Simi L, Cirami C & Parenti G 2007 Genetic screening for pheochromocytoma: should SDHC gene analysis be included? Journal of Medical Genetics 44 586-587. (doi:10.1136/jmg.2007.051045)
18. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacche M, Mori L, Pignataro V, Bernini G, Giache V, Bacca A et al. 2009 Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Journal of Clinical Endocrinology and Metabolism 94 1541-1547. (doi:10.1210/jc.2008-2419)
19. Neumann H 2008 Pheochromocytoma. In Harrison's Principles of Internal Medicine, 18th edn. Eds DL Longo, AS Fauci, DL Kasper, SL Hauser, JL Jameson & J Loscalzo. New York, NY, USA: McGraw-Hill Professional.
20. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466. (doi:10.1056/NEJMoa020152)
21. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA et al. 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951. (doi:10.1001/jama.292.8.943)
22. Newcombe RG 1998 Two-sided confidence intervals for the single proportion: comparison of seven methods. Statistics in Medicine 17 857-872. (doi:10.1002/(SICI)1097-0258(19980430)17:8<857::AIDSIM777>3.0.CO;2-E)
23. Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, van Heerden J, Lteif AN & Young WF Jr 2006 Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118 1109-1117. (doi:10.1542/peds.2005-2299)
24. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F et al. 2010 Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature Genetics 42 229-233. (doi:10.1038/ng.533)
25. Ross JH 2000 Pheochromocytoma. Special considerations in children. Urologic Clinics of North America 27 393-402. (doi:10.1016/S0094-0143(05)70088- 4)
26. Stackpole RH, Melicow MM & Uson AC 1963 Pheochromocytoma in children. Report of 9 case and review of the first 100 published cases with follow-up studies. Journal of Pediatrics 63 314-330.
27. Timmers HJ, Brouwers FM, Hermus AR, Sweep FC, Verhofstad AA, Verbeek AL, Pacak K & Lenders JW 2008 Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. Endocrine-Related Cancer 15 1127-1133. (doi:10.1677/ERC-08- 0049)
28. Tischler AS 2008 Pheochromocytoma and extra-adrenal paraganglioma: updates. Archives of Pathology & Laboratory Medicine 132 1272-1284.
29. Wilson EB 1927 Propable interference, the law of succession, and statistical interference. Journal of the American Statistical Association 22 209-212. (doi:10.1080/01621459.1927.10502953)